MA MAXHEALTH
Max Healthcare Institute Q4 2026
MAMAXHEALTH

Max Healthcare Institute Q4 FY26 results (Jan–Mar 2026) and concall

Healthcare · Concall AI · Call held 22 May 2026

Management summary

  • Max Healthcare reported strong Q4 and FY26 results with double-digit growth in revenue and PAT.
  • Phased commissioning of brownfield capacity and operational efficiencies..
  • The company expanded its footprint with the acquisition of Kalinga Hospital and announced a significant greenfield investment in Lucknow.
  • Despite a temporary increase in ALOS and a dip in oncology revenue due to drug discontinuation, the company maintains a healthy balance sheet and robust expansion plans.

Source: Inve concall analysis and management guidance record.

Highlights

  • Network gross revenue for Q4 FY26 stood at INR 2,664 crore, reflecting a 10% YoY growth and 2% QoQ growth.

  • Network operating EBITDA for Q4 FY26 was INR 682 crore, growing 8% YoY and 5% QoQ.

  • Profit after Tax (PAT) for FY26 increased to INR 1,631 crore, a 22% growth over FY25.

  • Completed the acquisition of a controlling stake in Kalinga Hospital Limited, a 250-bed hospital in Bhubaneswar, marking entry into Eastern India.

What they filed

Q4 FY26: revenue up 12.2%, net profit up 7.2% against the same quarter last year.

₹ Cr · quarterly
Line itemQ3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue1,868 1,910 2,028 2,135 2,068 +11%2,143 +12%
EBITDA499 512 523 575 538 +8%606 +18%
Net profit239 319 308 491 301 +26%342 +7%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Guidance & targets

Capacity

  • Brownfield capacity operationalization Capacity · next 2-3 months · High confidence All beds operationalized
  • Gurgaon greenfield hospital capacity addition Capacity · during the year · High confidence 10% additional capacity

Source: Inve Guidance Tracker — management targets and direct quotes from the earnings call transcript.

Q&A highlights

2 direct
Contribution of brownfield beds to EBITDA Direct
So they are already contributing to EBITDA and it is not any form a negative contribution. But what happens is that you sort of get the better end of operating leverage as you go along because right now, for the total 1,000-odd beds, we have initiated a phased rollout of lesser b

Clarifies that new brownfield capacity is already accretive and will improve operating leverage as occupancy ramps up.

Asked by Neha Manpuria

Gurugram hospital commissioning timeline Direct
Yes, we are expecting commissioning by the end of the year. That is right.

Confirms the timeline for a key greenfield project, addressing previous delays.

Asked by Neha Manpuria

Unlock risks & concerns, Q1 FY27 watchlist, and full call analysis

You’re reading a preview. Opening the full call uses 1 concall credit and unlocks:

  • 7 risks, concerns & management red flags
  • 5 watchlist triggers for Q1 FY27
  • +12 more guidance targets & verbatim management quotes
  • +6 more analyst Q&A exchanges & evasion checks
  • Capital allocation & full section-by-section narrative

Sign in to use your monthly call allowance.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared and our regulatory disclaimer. · Share on WhatsApp · Scorecard image